ABSTRACT
The specific features of essential arterial hypertension (AH) were studied in patients with active pulmonary tuberculosis (PT) and in those with residual changes (RC) after prior PT. The prevalence of AH was defined in patients with PT in relation to age, gender, and clinical form of a tuberculous process. The study indicated that the prevalence of AH among patients with an active tuberculous process was less than in the general population and it amounted to 18.2%. It was more common in males aged less than 60 years and in females aged above 60 years. The prevalence of AH in fibrocavernous tuberculosis was less than that in other forms, which was associated with the impact of intoxication on blood vessels. The patients with RC after prior PT had more frequently AH than those with an active tuberculous process, as well as target organ changes and a severer course of AH.
Subject(s)
Blood Pressure/physiology , Hypertension , Tuberculosis, Pulmonary/complications , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Hypertension/complications , Hypertension/epidemiology , Hypertension/physiopathology , Male , Middle Aged , Prevalence , Retrospective Studies , Russia/epidemiology , Severity of Illness Index , Tuberculosis, Pulmonary/epidemiologyABSTRACT
The prevalence and some specific features of coronary heart disease (CHD) were studied in patients with pulmonary tuberculosis. Its prevalence was determined in relation to age, gender, and the type of a tuberculous process. ECG changes in ST segment and T wave were found in patients with pulmonary tuberculosis without concomitant CHD under intoxication. The diagnosis of CHD was established in 41 of 491 patients, which was 8.4%. CHD was more common in elderly and senile females. The clinical manifestation of CHD was observed in females of older age than in males; under the age of 60 years, the prevalence of CHD is less among the patients with pulmonary tuberculosis and above the age of 60 years, it does not differ from that in the general population. CHD most commonly manifests clinical signs in patients with residual changes after experienced pulmonary tuberculosis and in cirrhotic tuberculosis, i.e. when the tuberculosis process is less active.
Subject(s)
Myocardial Ischemia/epidemiology , Tuberculosis, Pulmonary/epidemiology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle AgedABSTRACT
To treat hemodynamic disorders, preductal was used in combination with antibacterial therapy in 30 patients with disseminated destructive pulmonary tuberculosis for a month. A control group comprising 31 patients was in parallel observed. Clinical, electrocardiographic, and echocardiographic studies were performed to evaluate the efficacy of preductal. The drug was found to promote improvements in left ventricular function and central hemodynamics as a decrease in end-systolic volume and increases in ejection fraction and stroke and minute volumes. Preductal exerted no significant effect on right ventricular dysfunction associated with chronic cor pulmonale.
